- Letter to Editor
- Open access
- Published:
Irrational proton pump inhibitor use during corticosteroid therapy
The Egyptian Journal of Internal Medicine volume 30, pages 173–174 (2018)
References
Jones MG, Tsega S, Cho HJ. Inappropriate prescription of Proton Pump Inhibitors in the setting of steroid use:a teachable moment. JAMA Intern Med 2016; 176:594–595.
Machado-Alba J, Fernández A, Castrillón JD, Campo CF, Echeverri LF, Gaviria A, et al. Prescribing patterns and economic costs of proton pump inhibitors in Colombia. Colomb Med (Cali) 2013; 44:13–18.
Dorlo TP, Jager NG, Beijnen JH, Schellens JH. Concomitant use of proton pump inhibitors and systemic corticosteroids. Ned Tijdschr Geneeskd 2013; 157:A5540–A5540.
Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open 2014; 4:e004587.
Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol 2013; 27:443–454.
Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev 2014; 12:CD010623.
Wedemeyer R-S., Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Saf 2014; 37: 201–211.
Bezabeh S, Mackey AC, Kluetz P, Jappar D, Korvick J. Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors. Oncologist 2012; 17:550–554.
MartÃnek J, Hlavova K, Zavada F, Seifert B, Rejchrt S, Urban O, Zavoral M. ‘A surviving myth’ – corticosteroids are still considered ulcerogenic by a majority of physicians. Scand J Gastroenterol 2010; 45: 1156–1161.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Agarwal, R., Baid, R. Irrational proton pump inhibitor use during corticosteroid therapy. Egypt J Intern Med 30, 173–174 (2018). https://doi.org/10.4103/ejim.ejim_2_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_2_18